These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7262161)

  • 1. A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
    Cavalli F; Klepp O; Renard J; Röhrt M; Alberto P
    Eur J Cancer (1965); 1981 Feb; 17(2):245-9. PubMed ID: 7262161
    [No Abstract]   [Full Text] [Related]  

  • 2. VP16-213 as a single agent in advanced testicular tumors.
    Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
    Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VP-16-213 (etoposide) in the management of germinal testis tumors.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of etoposide in testicular tumors].
    Tanahashi T; Matsumura Y; Ozaki Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Nasu Y; Ohmori H
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3074-7. PubMed ID: 3767390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide: a new anti-cancer agent.
    Arnold AM; Whitehouse JM
    Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VM-26 and VP-16 salvage therapy for refractory germinal testicular cancers].
    Miki T; Tomooka Y; Yoshimura K; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1609-16. PubMed ID: 2593435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
    Panduro J; Hansen M; Hansen HH
    Cancer Treat Rep; 1981; 65(7-8):703-4. PubMed ID: 7248987
    [No Abstract]   [Full Text] [Related]  

  • 11. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
    Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complete remission obtained in advanced testicular cancer treated by etoposide (NK-171)].
    Babaya K; Tsumatani K; Natsume O; Yoshie T; Kubota K; Ozono S; Hirao Y; Okajima E
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):604-7. PubMed ID: 2420282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

  • 14. Etoposide (VP 16-213; VePesid).
    Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
    [No Abstract]   [Full Text] [Related]  

  • 15. Etoposide (VP-16-213). Current status of an active anticancer drug.
    O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
    N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
    [No Abstract]   [Full Text] [Related]  

  • 16. Etoposide for therapy-resistant testicular tumors.
    Varini M; Cavalli F
    Cancer Treat Rev; 1982 Jun; 9 Suppl():73-8. PubMed ID: 7127337
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer.
    Grunberg SM; Felman IE; Gala KV; Johnson KB; Owens JC
    Am J Clin Oncol; 1985 Oct; 8(5):393-5. PubMed ID: 4061373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of oral VP 16-213 (etoposide) in patients with advanced head and neck cancer.
    Crivellari D; Veronesi A; Magri MD; Tirelli U; Comoretto R; Barzan L; Caruso G; Carbone A; Grigoletto E
    Tumori; 1985 Oct; 71(5):499-500. PubMed ID: 4060251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.